SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-036895
Filing Date
2021-07-16
Accepted
2021-07-16 16:06:54
Documents
12
Period of Report
2021-07-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K NATHALIE ADDA RETIREMENT enta-8k_20210714.htm   iXBRL 8-K 34312
  Complete submission text file 0001564590-21-036895.txt   159457

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA enta-20210714.xsd EX-101.SCH 5768
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20210714_lab.xml EX-101.LAB 18714
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20210714_pre.xml EX-101.PRE 11169
5 EXTRACTED XBRL INSTANCE DOCUMENT enta-8k_20210714_htm.xml XML 3400
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35839 | Film No.: 211095558
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences